• Clinical Insights
  • Partnering with Genoa

Webinar: Improving Resident Satisfaction & Outcomes by Integrating Pharmacy Services

Oct 1st, 2021

Webinar Brief

The delivery of consumer services is on the rise in residential, group homes, and assisted living community settings, as consumers shy away from acute care and skilled nursing facilities. How do management teams ensure quality service, high satisfaction scores, and financial stability with this model?

Genoa Healthcare recently hosted a panel discussion with three assisted living executives where they discussed improving the value proposition of their residential services by integrating pharmacy support services.

Left to right: Anthony Zerilli, Franchise Operations Manager for Majestic Residences; Vicki Powell, Director of Business Development for SYNERGY HomeCare; and Kelly Anne Deshaies, RN BSN, Director of Nursing at Community Living of Rhode Island.

Anthony Zerilli, Franchise Operations Manager for Majestic Residences; Vicki Powell, Director of Business Development for SYNERGY HomeCare; and Kelly Anne Deshaies, RN BSN, Director of Nursing at Community Living of Rhode Island joined Genoa Healthcare’s Vice President of Business Development, Assisted Living, Stacey Bane, PharmD, to discuss how their communities leverage integrated pharmacy services to:

  • Navigate census and staffing issues amid the pandemic
  • Ease staff burden and improve workflow efficiencies
  • Drive higher resident and family member satisfaction

To learn more about how Genoa can help you and those you serve, contact us today.

Recent Posts


  • Behavioral Health
  • Clinical Insights
  • Treatment
Why medication-assisted treatment is essential for improving patient outcomes

1. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH. 2. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH....

  • 340B
Your questions, answered: 340B manufacturer pricing restrictions

Drug manufacturers began implementing restrictions for 340B pricing in 2020, citing alleged misuse by safety-net providers and explosive growth of the 340B Drug Pricing Program. Since then, restrictions for the...

  • Behavioral Health
  • Clinical Insights
  • Treatment
Currently available and emerging therapy options for treatment-resistant depression

Studies show that 50% of people with major depressive disorder don’t respond adequately to initial antidepressant treatment.1 Additionally, an estimated 30% of people with major depressive disorder (MDD) experience treatment-resistant...

  • Art Celebration
  • Consumer Stories
  • People-first Pharmacy Care
Genoa Art Celebration participant heals through art, helps others after losing daughter to substance use disorder

Content warning: This post discusses mental illness and substance use. Please call the Suicide and Crisis Lifeline at 988, the Substance Abuse and Mental Health Services Administration’s National Helpline at...